Abstract. The phagocyte function of granulocytes and monocytes of whole blood was measured as superoxide production in patients treated for acute nonlymphoblastic leukaemia. The results indicate that the antileukaemic protocol used in this study did not cause a decrase of the oxidative metabolism triggered by phagocytosis and by phorbol esters.
Introduction
One of the parameters that are usually followed during the treatment of cancer patients is the leukocyte count. However, it would be also relevant for the clinician to know the functional capacity of the leukocytes during therapy. It has been reported that drugs used in cancer patients such as prednisone or methotrexate inhibit leukocyte function [-3] . Concomi- tantly with neutropenia, such an effect is expected to markedly increase the risk of infection.
We have utilized a quantitative assay of superoxide (O1) production in whole blood [a-6] 6 -thioguanine (6-TG; 200 mg / m2 / day , days 1 -7), alternated with a cycle consisting of ADM (50mg/m2/day, day 1), vincristine (VCR; 1.3 mg/m2/d,ay, day 2) and ARA-C \1 mE/m2/day, days l-6). Alter three cycles, also amsacrine (AMSA, l00mg/ml/day, days 1-5) and etoposide (VPl6, 100 mg/m2/day, days l-5) were given as consolidation chemotherapy.
The phagocyte function was measured as O1 production according to the method ol Bellavite et al. [6] : I -2 ml ol heparinized (20 U,/ml) venous blood were withdrawn and utilized lor the assay within 2 h; lor each blood sample duplicate assays of O1 production in the absence and in the presence of opsonized zymosan ( 1 mglml) and of phorbol l2-myristate l3-acetate (PMA; I pg/ml) as stimulatory agents were done. On the same blood sample the leukocyte count and formula were done and the number ol phagocytes was reported as the sum of mature granulocytes plus hall of mature monocytes, because monocytes have about half the capacity ol superoxide production with respect to granulocytes [6] . The patients considered in this study had small numbers of circulating immature myeloid precursors (less than 5,000,/mm3 before therapy, less than 1,200 during therapy). The presence ofblasts did not aflect the assay of O; production because it is known that in these cells the respiratory burst is almost totally absent [5, 7, 8] .
Results and Discussion Figure I shows the course of the phagocyte numbers and superoxide-producing capacity of whole blood in two ANLL patients during the first three months of therapy. It can be seen that the initial chemotherapeutic cycle induced a rapid decrease of both phagocyte number and superoxide production 
